THE TIMING OF SURGERY FOR RESECTABLE METACHRONOUS LIVER METASTASES FROM COLORECTAL CANCER: BETTER SOONER THAN LATER
2010-01-01 Pistelli, M; Scartozzi, Mario; Siquini, W; Galizia, E; Marmorale, C; Stortoni, P; Berardi, R; Fianchini, A; Cascinu, S.
PHARMACOGENETIC TAILORED FIRST-LINE CHEMOTHERAPY IN ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER. A PHASE II, PROSPECTIVE STUDY
2010-01-01 Bittoni, A; Scartozzi, Mario; Loretelli, C; Giampieri, R; Berardi, R; Pierantoni, C; Silva, Rr; Mari, D; Galizia, E; Cascinu, S.
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan/cetuximab
2011-01-01 Scartozzi, Mario; Mandolesi, A; Giampieri, R; Zaniboni, A; Galizia, E; Giustini, L; Silva, Rr; Berardi, R; Bearzi, I; Cascinu, S.
Analysis of polymorphisms in the interleukin-1beta gene (IL-1B) and interleukin-1 receptor antagonist gene (IL-1RN) for gastric cancer susceptibility in helicobacter Pylori negative Italian patients. A report from the Italian Group for Genetic Research in Gastric Cancer (IGGRGC).
2004-01-01 Ruzzo, A; Pizzagalli, F; Graziano, F; Santini, D; Catalano, V; Scartozzi, Mario; Ficarelli, R; Bearzi, I; Cascinu, S; Magnani, M.
Epidermal growth factor receptor (EGFR) status in primary colorectal tumours does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted antibodies.
2004-01-01 Scartozzi, Mario; Bearzi, I; Berardi, R; Mandolesi, A; Freddari, F; Graziano, F; Catalano, V; Baldelli, Am; Silva, Rr; Cascinu, S.
Hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab.
2008-01-01 Scartozzi, Mario; Galizia, E; Chiorrini, S; Berardi, R; Siquini, W; Cascinu S., ESMO International Symposium
EGFR downstream signaling pathway in primary colorectal tumours and related metastatic sites: optimizing EGFR targeted treatment options.
2005-01-01 Scartozzi, Mario; Bearzi, I; Berardi, R; Mandolesi, A; Pierantoni, C; Cascinu S., EGFR downstream signaling pathway in primary colorectal tumours; Ann Oncol, related metastatic sites: optimizing EGFR targeted treatment o. p. t. i. o. n. s.; In, Stampa
Epidermal growth factor receptor (EGFR) gene copy number (GCN) detected by chromogenic in situ hybridization (CISH) correlates with clinical activity of irinotecan-cetuximab in colorectal cancer.
2008-01-01 Scartozzi, Mario; Bearzi, I; Pierantoni, C; Mandolesi, A; Berardi, R; Loupakis, F; Galizia, E; Zaniboni, A; Falcone, A; Cascinu, S.
Hemoglobin level may influence the outcome of patients undergoing neoadjuvant treatment for rectal cancer. , abstr. 210 (poster session)
2005-01-01 Berardi, R; Mantellog, ; Scartozzi, Mario; Bertolini, F; Luppi, G; Martinelli, R; Fumagalli, M; Del Prete, S; Grillo Ruggieri, F; S., Cascinu
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
2004-01-01 Scartozzi, Mario; Labianca, R; Catalano, V; Silva, Rr; Barni, S; D'Angelo, A; Zaniboni, A; Salvagni, S; Martignoni, G; Beretta, Gd; Graziano, F; Berardi, R; Franciosi, V; Cascinu, S.
COX-2 and NF-KB overexpression does not predict for celecoxib activity in combination with gemcitabine (GEM) and oxaliplatin (LH-OP) in advanced pancreatic cancer (PC).
2006-01-01 Berardi, R; Scartozzi, Mario; Carbonari, G; Silva, Rr; Mari, D; Massacesi, C; Pierantoni, C; Squadroni, M; Antognoli, S; Cascinu, S.
The timing of surgery for resectable liver metastases from colorectal cancer: Better sooner than later
2009-01-01 Scartozzi, Mario; Galizia, E; Siquini, W; Marmorale, C; Berardi, R; Fianchini, A; Stortoni, P; Pagliacci, A; Cascinu, S.
5-Fluorouracil (5FU) is beneficial in patients with metastatic colorectal cancer progressing after 5FU-based first line chemotherapy.
2004-01-01 Berardi, R; Scartozzi, Mario; Labianca, R; Sobrero, A; Catalano, G; Catalano, V; Graziano, F; Barni, S; Zaniboni, A; Beretta, Gd; Cascinu, S.
Extended lymphadenectomy is a curative procedure in inoperable gastric cancer patients. , abstr. 78 (poster session)
2004-01-01 Galizia, E; Scartozzi, Mario; Graziano, F; Catalano, V; Berardi, R; Baldelli, A; Testa, E; Catalano, G; Cellerino, R; Cascinu, S.
Correlation of insulin-like growth factor 1 (IGF-1) expression and clinical outcome in K-RAS wild-type colorectal cancer patients treated with cetuximab-irinotecan.
2009-01-01 Scartozzi, Mario; Bearzi, I; Mandolesi, A; Loupakis, F; Zaniboni, A; Berardi, R; Pierantoni, C; Masi, G; Falcone, A; Cascinu, S.
Preoperative chemotherapy plus concomitant radiotherapy in rectal cancerpatients (pts). updated results of a phase II study
2003-01-01 Scartozzi, Mario; Galizia, E; Antognoli, S; Bracci R., Grillo Ruggieri F; Mantello, G; Marmorale, C; Berardi R., Cascinu S; Cellerino, R.
Correlation of biliary stenting with clinical outcome in patients with advanced pancreatic cancer treated with chemotherapy.
2012-01-01 Faloppi, L; Maccaroni, E; Giampieri, R; Bianconi, M; Bittoni, A; Del Prete, M; Antognoli, S; Scartozzi, Mario; Cascinu, S.
The role of LDH serum levels in predicting global outcome in patients with HCC undergoing TACE: Implications for clinical management.
2012-01-01 Bianconi, M; Faloppi, L; Scartozzi, Mario; Giampieri, R; Maccaroni, E; Bittoni, A; Del Prete, M; Loretelli, C; Belvederesi, L; Svegliati Baroni, Gl; Cascinu, S.
Intensive up-front treatment versus a sequential approach in advanced gastric cancer patients: Does first line matter?
2012-01-01 Bittoni, A; Scartozzi, Mario; Pistelli, M; Galizia, E; Del Prete, M; Giampieri, R; Faloppi, L; Bianconi, M; Maccaroni, E; Cascinu, S.
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for patients with advanced renal cell carcinoma receiving first-line sunitinib
2012-01-01 Bianconi, M; Scartozzi, Mario; Luca, Faloppi; Giampieri, R; Maccaroni, E; Bittoni, A; Del Prete, M; Loretelli, C; Belvederesi, L; Conti, A; Minardi, D; Burattini, L; Montironi, R; Cascinu, S.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 4 Contributo in Atti di Convegno ...1252
Data di pubblicazione
- In corso di stampa9
- 2020 - 202659
- 2010 - 2019690
- 2000 - 2009431
- 1990 - 199949
- 1983 - 198914
Editore
- Society for Neurosciences6
- DOPAMINE 20135
- EGU General Assembly 20145
- Association for Computing Machinery4
- Società Botanica Italiana4
- Coluzzi M.3
- Society for Neuroscience3
- Società Chimica Italiana3
- UZI Unione Zoologica Italiana3
- Associazione Italiana di Acustica...2
Rivista
- ANNALS OF ONCOLOGY26
- SOCIETY FOR NEUROSCIENCE17
- JOURNAL OF CLINICAL ONCOLOGY16
- COLORECTAL DISEASE6
- EUROPEAN JOURNAL OF HUMAN GENETICS6
- PARASSITOLOGIA6
- ACTA OF THE INTERNATIONAL SYMPOSI...5
- ALLERGY3
- AMERICAN JOURNAL OF MEDICAL GENET...3
- EUROPEAN JOURNAL OF CANCER3
Serie
- ACTA OF THE INTERNATIONAL SYMPOSI...2
- EDULEARN PROCEEDINGS1
Keyword
- electronic properties12
- Sardinia5
- Climate change4
- electronic properties of clusters3
- Electronic properties of molecules3
- GEOPHYSICAL METHODS3
- antidepressants2
- bnst2
- catecholamines2
- Coastal aquifer2
Lingua
- eng631
- ita165
- spa5
- fre3
Accesso al fulltext
- no fulltext1236
- reserved11
- open5